This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. We trust, this report will help diagnostic products suppliers develop more effective business, R&D and marketing strategies. Research Beam Model: Research Beam Product ID: 15660 7500 USD New
2014 Strategies for the US Ancillary Hospital Locations (ERs, ORs, ICUs) Diagnostic Testing Market
 
 

2014 Strategies for the US Ancillary Hospital Locations (ERs, ORs, ICUs) Diagnostic Testing Market

  • Category : Diagnostic and Biotech
  • Published On : January   2014
  • Pages : 0
  • Publisher : VPGMarketResearch.com
 
 
 

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs).  The report includes analysis of the market dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.  We trust, this report will help diagnostic products suppliers develop more effective business, R&D and marketing strategies.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals closer to the patient.

Market Segmentation Analysis

- Review of the ER, OR and ICU market segments, including their dynamics, trends,
  structure, size,  growth and major suppliers.

- Five-year test volume and sales forecasts for chemistry, immunodiagnostic, microbiology,
  hematology and coagulation procedures by market segment:

- Emergency Rooms               
- Operating/Recovery Suites
- ICUs/CCUs

and test category:

- Routine and Special Chemistry
- Microbiology/Infectious Diseases
- Hematology
- Flow Cytometry
- Coagulation
- Immunoproteins
- Drugs of Abuse
- TDM
- Endocrine Function
- Tumor Markers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Current and Emerging Products

- Analysis of over 130 diagnostic procedures.

- Review of leading POC chemistry, immunoassay, hematology and coagulation analyzers,
  both currently marketed and those in development, including their operating characteristics,
  features and selling prices.

Technology Review

- Emerging technologies and their applications for POC testing.

- Comprehensive listings of companies developing or marketing POC diagnostic technologies
  and products, by test.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales,
  product portfolios,  marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially
  significant market appeal during the next ten years.

- Design criteria for POC testing products.

- Alternative business expansion strategies.

- Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and Venture Planning Group's proprietary data files.

Contains 973 pages and 153 tables

 

../toc/TOCTOTDiagnosticTestingintheUSAncillaryHospitalLocations.pdf
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT